Main Article Content
OBJECTIVE. The purpose of this research was to reduce rate of CRBSI at Bangkok Hospital by using 2002 CDC evidence-based guidelines as a preventive of CRBSI.1
MATERIALS AND METHODS. A target surveillance on CRBSI was conducted in all 4 adult intensive care units at the Bangkok Hospital. The findings were compared with the CDC recommendations. Then we set up a multidisciplinary patient-care project team who applied the CDC guidelines in order to work towards the reduction and eventual prevention of CRBSI’s in our hospital.
RESULTS. The reduction of CRBSI incidence was observed to be sustainable after the new guidelines were implemented in October 2004. The rate of CRBSI incidence reduced gradually especially in the year of 2010. It approached to zero per 1000 catheter-day.
CONCLUSION. Nowadays, all healthcare personnel must take responsibility for preventing nosocomial infection. We has demon- trated that our multidisciplinary team can reduce the infection rates sC
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Pittet D, Tarara D, Wenzel R. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601.
3. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of out-come of intravenous catheter-related infections in critically ill patients, Am J Respir Crit Care Med 2000;162:1027-30.
4. Kluger D, Maki DG. The relative risk of intravenous device-related bloodstream infection with different types
of intravenous devices in adults: a meta-analysis of 206 published studies (abstract). Infect Control Hosp Epidemiol 2000;21:95-6.
5. Coopersmith CM, Rebmann TL, Zack JE, et al. Effect of an education program on dressing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002;30:59-64.
6. Sherertz RJ, Ely FW, Westhrook DM, et al. Education of physicians in-training can decrease the risk for vascular catheter infection. Ann Inter Med 2000;132:641-8.
7. Mermel LA and Maki DG. Infection complications of Swan-Ganz pulmonary artery catheter. Pathogenesis, Crit Care Med 1994;149:1020-36.
8. Maki DG, Ringer M and Alvarado CJ. Prospective randomized trial of providone-iodine, alcohol, and chlorhexidinefor prevention of infection associated with centralvenous and arterial catheter. Lancet 1991;338:339-43.
9. Mimoz O, Pieroni L, Lawrene C, et al. Prospective randomized trial of two antiseptic solution for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996;24:1818-2.
10. Maki DG, Stolz SS, Wheeler S, et al. A prospective, randomized trial of gauze and two polyurethane dressing for site care of pulmonary artery catheters: implications for catheter management unit care. Med 1994;22:1729-37.
11. Mermal LA, McCornick RD, Springman SR, et al. The pathogenesis and epidermology of catheter related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91:197-205.
12. Parienti JJ, Thirion M, Megarbrane B, et al. Femoral vs. Jugular venous catherterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008;299:2413-22.
13. Danchaivijitr S, Judaung T, Sripalakj S et al. Prevalence of Nosocomial Infection in Thailand 2006. J Med Assoc Thai 2007;90:1524-9.
14. O’Grady NP, Alexads M, Burns LA, et al. Guideline for the Prevention of Intravascular Catheter-Related Infections 2011.